ID FEM1A_HUMAN Reviewed; 669 AA. AC Q9BSK4; B2RDI3; Q711P8; Q9NPN7; Q9NPW8; DT 18-MAR-2008, integrated into UniProtKB/Swiss-Prot. DT 01-JUN-2001, sequence version 1. DT 07-OCT-2020, entry version 169. DE RecName: Full=Protein fem-1 homolog A; DE Short=FEM1a; DE AltName: Full=FEM1-alpha; DE AltName: Full=Prostaglandin E receptor 4-associated protein; GN Name=FEM1A; Synonyms=EPRAP; OS Homo sapiens (Human). OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia; OC Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae; OC Homo. OX NCBI_TaxID=9606; RN [1] RP NUCLEOTIDE SEQUENCE [MRNA], TISSUE SPECIFICITY, AND INTERACTION WITH RP PTGER4. RX PubMed=16424369; DOI=10.1161/01.res.0000204451.88147.96; RA Takayama K., Sukhova G.K., Chin M.T., Libby P.; RT "A novel prostaglandin E receptor 4-associated protein participates in RT antiinflammatory signaling."; RL Circ. Res. 98:499-504(2006). RN [2] RP NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]. RC TISSUE=Placenta; RX PubMed=14702039; DOI=10.1038/ng1285; RA Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R., RA Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H., RA Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S., RA Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K., RA Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H., RA Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M., RA Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K., RA Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T., RA Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M., RA Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S., RA Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H., RA Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K., RA Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N., RA Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S., RA Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O., RA Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H., RA Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B., RA Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y., RA Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K., RA Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T., RA Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T., RA Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y., RA Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H., RA Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y., RA Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H., RA Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O., RA Isogai T., Sugano S.; RT "Complete sequencing and characterization of 21,243 full-length human RT cDNAs."; RL Nat. Genet. 36:40-45(2004). RN [3] RP NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]. RC TISSUE=Kidney; RX PubMed=15489334; DOI=10.1101/gr.2596504; RG The MGC Project Team; RT "The status, quality, and expansion of the NIH full-length cDNA project: RT the Mammalian Gene Collection (MGC)."; RL Genome Res. 14:2121-2127(2004). RN [4] RP NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 2-669. RC TISSUE=Skeletal muscle; RA Ievolella C., Zara I., Millino C., Faulkner G., Lanfranchi G.; RT "Full length sequencing of an human and murine muscular transcripts RT (Telethon Italy project B41)."; RL Submitted (MAY-2001) to the EMBL/GenBank/DDBJ databases. RN [5] RP NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 470-669. RG The European IMAGE consortium; RL Submitted (JUL-2000) to the EMBL/GenBank/DDBJ databases. RN [6] RP NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 576-669. RC TISSUE=Melanoma; RX PubMed=17974005; DOI=10.1186/1471-2164-8-399; RA Bechtel S., Rosenfelder H., Duda A., Schmidt C.P., Ernst U., RA Wellenreuther R., Mehrle A., Schuster C., Bahr A., Bloecker H., Heubner D., RA Hoerlein A., Michel G., Wedler H., Koehrer K., Ottenwaelder B., Poustka A., RA Wiemann S., Schupp I.; RT "The full-ORF clone resource of the German cDNA consortium."; RL BMC Genomics 8:399-399(2007). RN [7] RP INDUCTION. RX PubMed=16254458; DOI=10.1159/000089261; RA Ventura-Holman T., Hahn H., Subauste J.S., Maher J.F.; RT "The Fem1a gene is downregulated in Rhabdomyosarcoma."; RL Tumor Biol. 26:294-299(2005). RN [8] RP VARIANT TYR-500. RX PubMed=16390781; DOI=10.1080/09513590500431458; RA Maher J.F., Hines R.S., Futterweit W., Crawford S., Lu D., Shen P., RA Oefner P., Kazi M., Wilson J.G., Subauste J.S., Cowan B.D.; RT "FEM1A is a candidate gene for polycystic ovary syndrome."; RL Gynecol. Endocrinol. 21:330-335(2005). CC -!- FUNCTION: Probable component of an E3 ubiquitin-protein ligase complex, CC in which it may act as a substrate recognition subunit (By similarity). CC May participate in antiinflammatory signaling via its interaction with CC PTGER4. {ECO:0000250}. CC -!- PATHWAY: Protein modification; protein ubiquitination. CC -!- SUBUNIT: Component of some E3 ubiquitin-protein ligase complex (By CC similarity). Interacts with PTGER4. {ECO:0000250, CC ECO:0000269|PubMed:16424369}. CC -!- INTERACTION: CC Q9BSK4; P09110: ACAA1; NbExp=3; IntAct=EBI-2515349, EBI-3926709; CC Q9BSK4; A6NEM1: GOLGA6L9; NbExp=3; IntAct=EBI-2515349, EBI-5916454; CC Q9BSK4; Q0VD86: INCA1; NbExp=3; IntAct=EBI-2515349, EBI-6509505; CC Q9BSK4; Q9BVG8-5: KIFC3; NbExp=3; IntAct=EBI-2515349, EBI-14069005; CC Q9BSK4; Q9UDY8-2: MALT1; NbExp=3; IntAct=EBI-2515349, EBI-12056869; CC Q9BSK4; Q5VTT5-2: MYOM3; NbExp=3; IntAct=EBI-2515349, EBI-12247808; CC Q9BSK4; O14561: NDUFAB1; NbExp=3; IntAct=EBI-2515349, EBI-1246261; CC Q9BSK4; Q8N543: OGFOD1; NbExp=3; IntAct=EBI-2515349, EBI-13327083; CC Q9BSK4; Q9NZC7-5: WWOX; NbExp=3; IntAct=EBI-2515349, EBI-12040603; CC -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000305}. CC -!- TISSUE SPECIFICITY: Present in macrophages derived from peripheral CC blood monocytes. Also present in atheromata (at protein level). CC {ECO:0000269|PubMed:16424369}. CC -!- INDUCTION: Frequently down-regulated in rhabdomyosarcoma. CC {ECO:0000269|PubMed:16254458}. CC -!- SIMILARITY: Belongs to the fem-1 family. {ECO:0000305}. CC --------------------------------------------------------------------------- CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms CC Distributed under the Creative Commons Attribution (CC BY 4.0) License CC --------------------------------------------------------------------------- DR EMBL; AY356352; AAR10439.1; -; mRNA. DR EMBL; AK315554; BAG37930.1; -; mRNA. DR EMBL; BC004988; AAH04988.1; -; mRNA. DR EMBL; AJ311359; CAC85342.1; -; mRNA. DR EMBL; AL365408; CAB96952.1; -; mRNA. DR EMBL; AL359589; CAB94875.1; -; mRNA. DR EMBL; CR749732; CAH18491.1; -; mRNA. DR CCDS; CCDS12135.1; -. DR PIR; T50619; T50619. DR RefSeq; NP_061178.1; NM_018708.2. DR SMR; Q9BSK4; -. DR BioGRID; 120699; 25. DR IntAct; Q9BSK4; 20. DR STRING; 9606.ENSP00000269856; -. DR iPTMnet; Q9BSK4; -. DR PhosphoSitePlus; Q9BSK4; -. DR BioMuta; FEM1A; -. DR DMDM; 74752305; -. DR EPD; Q9BSK4; -. DR jPOST; Q9BSK4; -. DR MassIVE; Q9BSK4; -. DR MaxQB; Q9BSK4; -. DR PaxDb; Q9BSK4; -. DR PeptideAtlas; Q9BSK4; -. DR PRIDE; Q9BSK4; -. DR ProteomicsDB; 78912; -. DR Antibodypedia; 11533; 140 antibodies. DR DNASU; 55527; -. DR Ensembl; ENST00000269856; ENSP00000269856; ENSG00000141965. DR GeneID; 55527; -. DR KEGG; hsa:55527; -. DR UCSC; uc002mbf.4; human. DR CTD; 55527; -. DR DisGeNET; 55527; -. DR EuPathDB; HostDB:ENSG00000141965.4; -. DR GeneCards; FEM1A; -. DR HGNC; HGNC:16934; FEM1A. DR HPA; ENSG00000141965; Tissue enriched (skeletal). DR MIM; 613538; gene. DR neXtProt; NX_Q9BSK4; -. DR OpenTargets; ENSG00000141965; -. DR PharmGKB; PA134940973; -. DR eggNOG; KOG0508; Eukaryota. DR GeneTree; ENSGT00940000161210; -. DR HOGENOM; CLU_020042_2_0_1; -. DR InParanoid; Q9BSK4; -. DR OMA; DHCGARV; -. DR OrthoDB; 252380at2759; -. DR PhylomeDB; Q9BSK4; -. DR TreeFam; TF351376; -. DR PathwayCommons; Q9BSK4; -. DR Reactome; R-HSA-8951664; Neddylation. DR UniPathway; UPA00143; -. DR BioGRID-ORCS; 55527; 30 hits in 851 CRISPR screens. DR ChiTaRS; FEM1A; human. DR GenomeRNAi; 55527; -. DR Pharos; Q9BSK4; Tbio. DR PRO; PR:Q9BSK4; -. DR Proteomes; UP000005640; Chromosome 19. DR RNAct; Q9BSK4; protein. DR Bgee; ENSG00000141965; Expressed in skeletal muscle tissue and 214 other tissues. DR Genevisible; Q9BSK4; HS. DR GO; GO:0005829; C:cytosol; TAS:Reactome. DR GO; GO:0000151; C:ubiquitin ligase complex; IBA:GO_Central. DR GO; GO:0031867; F:EP4 subtype prostaglandin E2 receptor binding; IPI:UniProtKB. DR GO; GO:0050728; P:negative regulation of inflammatory response; IDA:UniProtKB. DR GO; GO:0043687; P:post-translational protein modification; TAS:Reactome. DR GO; GO:0016567; P:protein ubiquitination; IEA:UniProtKB-UniPathway. DR GO; GO:0051438; P:regulation of ubiquitin-protein transferase activity; ISS:UniProtKB. DR GO; GO:0006511; P:ubiquitin-dependent protein catabolic process; IBA:GO_Central. DR Gene3D; 1.25.40.10; -; 1. DR Gene3D; 1.25.40.20; -; 3. DR InterPro; IPR002110; Ankyrin_rpt. DR InterPro; IPR020683; Ankyrin_rpt-contain_dom. DR InterPro; IPR036770; Ankyrin_rpt-contain_sf. DR InterPro; IPR011990; TPR-like_helical_dom_sf. DR Pfam; PF12796; Ank_2; 4. DR PRINTS; PR01415; ANKYRIN. DR SMART; SM00248; ANK; 9. DR SUPFAM; SSF48403; SSF48403; 2. DR SUPFAM; SSF48452; SSF48452; 1. DR PROSITE; PS50297; ANK_REP_REGION; 2. DR PROSITE; PS50088; ANK_REPEAT; 7. PE 1: Evidence at protein level; KW ANK repeat; Cytoplasm; Polymorphism; Reference proteome; Repeat; KW TPR repeat; Ubl conjugation pathway. FT CHAIN 1..669 FT /note="Protein fem-1 homolog A" FT /id="PRO_0000324525" FT REPEAT 2..31 FT /note="ANK 1" FT REPEAT 40..70 FT /note="ANK 2" FT REPEAT 82..111 FT /note="ANK 3" FT REPEAT 115..145 FT /note="ANK 4" FT REPEAT 149..178 FT /note="ANK 5" FT REPEAT 182..211 FT /note="ANK 6" FT REPEAT 214..243 FT /note="ANK 7" FT REPEAT 298..332 FT /note="TPR 1" FT REPEAT 390..423 FT /note="TPR 2" FT REPEAT 534..576 FT /note="ANK 8" FT REPEAT 580..609 FT /note="ANK 9" FT VARIANT 500 FT /note="H -> Y (found in a patient with polycystic ovary FT syndrome; unknown pathological significance)" FT /evidence="ECO:0000269|PubMed:16390781" FT /id="VAR_039809" SQ SEQUENCE 669 AA; 73639 MW; FF0010DE5207D48F CRC64; MDLRTAVYNA ARDGKLQLLQ KLLSGRSREE LDELTGEVAG GGTPLLIAAR YGHLDVVEYL VDRCGASVEA GGSVHFDGET IEGAPPLWAA SAAGHLDVVR SLLRRGASVN RTTRTNSTPL RAACFDGHLE VVRYLVGEHQ ADLEVANRHG HTCLMISCYK GHREIARYLL EQGAQVNRRS AKGNTALHDC AESGSLEILQ LLLGCKARME RDGYGMTPLL AASVTGHTNI VEYLIQEQPG QEQVAGGEAQ PGLPQEDPST SQGCAQPQGA PCCSSSPEEP LNGESYESCC PTSREAAVEA LELLGATYVD KKRDLLGALK HWRRAMELRH QGGEYLPKPE PPQLVLAYDY SREVNTTEEL EALITDPDEM RMQALLIRER ILGPSHPDTS YYIRYRGAVY ADSGNFERCI RLWKYALDMQ QSNLEPLSPM TASSFLSFAE LFSYVLQDRA AKGSLGTQIG FADLMGVLTK GVREVERALQ LPREPGDSAQ FTKALAIILH LLYLLEKVEC TPSQEHLKHQ TVYRLLKCAP RGKNGFTPLH MAVDKDTTNV GRYPVGRFPS LHVVKVLLDC GADPDSRDFD NNTPLHIAAQ NNCPAIMNAL IEAGAHMDAT NAFKKTAYEL LDEKLLARGT MQPFNYVTLQ CLAARALDKN KIPYKGFIPE DLEAFIELH //